BGI AU Contributes to Safeguarding Queensland from COVID-19
BGI Australia is proud to be the supplier for Pathology Queensland’s testing equipment and kits, contributing to safeguarding the people living in Queensland. BGI’s proprietary COVID-19 Testing Solution installed in the Pathology Queensland Infectious Diseases Lab (IDL) in Herston Health Precinct has officially started operation in April by running samples that are collected from across the river city. The “BGI system”, dubbed by the lab staff, surpassed the 10,000-test milestone in less than a month. The integrated system is expected to handle 4,700 tests daily at the maximum capacity, with a 24-hour turnaround time from swab collection at a clinic or hospital, to reported result.
Dr. Ian Mackay, the IDL’s Senior Molecular Scientist said, “our approach is to establish a diverse portfolio of advanced technologies to best serve Queenslanders. We appreciate how quickly the BGI team respond to our ongoing technical needs and how efficiently the equipment and testing kits were supplied. We are handling approximately 1,100 tests per day as there is no community transmission in the Brisbane region, but the number we process continues to grow and we are well placed to respond should any new clusters occur in Brisbane’s future.”
With a local team of technical specialists and engineers, BGI Australia offers strong support to the customers across Australia. Dr. Bicheng Yang, Director of BGI Australia, said “This project is very special for us as Brisbane is our home city, where most of the team members are based, and we are located in the same building as IDL. This certainly will benefit response time and service to ensure that everything runs smoothly and sustains the highest quality to deliver reliable results for the tests.”
The Pathology Queensland Infectious Diseases Laboratory is a high-throughput molecular laboratory operating in Herston, with surge capacity to assist other Pathology Queensland laboratories across Queensland. Pathology Queensland, part of Queensland Health, provides diagnostic pathology services to all Hospital and Health Services across metro, regional and remote Queensland.
Please read the full media release below.
What's New
COVID-19 Updates
Promotions & Grants
COVID-19 Updates
BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.
News
Promotions & Grants
COVID-19 Updates
Check in on the latest news at BGI Australia.
- BGI partners with Minderoo to launch Huo-Yan Laboratory Solution to expedite Australia-wide COVID-19 testing.
Promotions & Grants
Promotions & Grants
Promotions & Grants
Keep an eye out here for our promotions and grants. Be notified when applications open.
- Human WGS promotion. Offer ends Nov 30, 2020.
- Human WES promotion. Offer ends Nov 30, 2020.
Explore
Core Capability
Core Capability
Core Capability
Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources,
Research
Core Capability
Core Capability
BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.
Instruments
Core Capability
Instruments
Check out our latest range of MGI sequencing platforms and diagnostic devices.
Services
Customer Testimonials
Instruments
We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.
Partners
Customer Testimonials
Customer Testimonials
We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.
Customer Testimonials
Customer Testimonials
Customer Testimonials
We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.
